The effectiveness and safety of the difluoroquinolone sparflo (sparfloxacine) used in combined therapy for drug-sensitive and drug-resistant pulmonary tuberculosis were studied. Clinical trials were carried out in 60 patients with severe pulmonary tuberculosis. The more effective combinations of sparfo and other antituberculous drugs were determined. Data on the satisfactory tolerability of sparfo used in various combinations of first- and second-line agents are presented.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
effectiveness safety
8
sparfloxacine combined
8
combined therapy
8
pulmonary tuberculosis
8
[the effectiveness
4
safety sparfloxacine
4
therapy tuberculosis]
4
tuberculosis] effectiveness
4
safety difluoroquinolone
4
difluoroquinolone sparflo
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!